These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2052204)

  • 1. Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity.
    Chambers JP; Hartgraves SL; Murphy MR; Wayner MJ; Kumar N; Valdes JJ
    Neurosci Biobehav Rev; 1991; 15(1):85-8. PubMed ID: 2052204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
    Yang ZP; Dettbarn WD
    Biochem Pharmacol; 1998 May; 55(9):1419-26. PubMed ID: 10076534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide).
    Clement JG; Erhardt N
    Arch Toxicol; 1990; 64(5):414-6. PubMed ID: 2403290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of aliesterase in organophosphate poisoning.
    Clement JG
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S96-105. PubMed ID: 6724216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin-2-oxide on tissue cholinesterase and carboxylesterase activities of the rat.
    Jimmerson VR; Shih TM; Maxwell DM; Kaminskis A; Mailman RB
    Fundam Appl Toxicol; 1989 Oct; 13(3):568-75. PubMed ID: 2612789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
    Jimmerson VR; Shih TM; Maxwell DM; Mailman RB
    Toxicol Lett; 1989 Jul; 48(1):93-103. PubMed ID: 2749782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro deacetylation studies with isomeric acetamidobiphenyls using selective carboxylesterase inhibitors.
    Sertkaya NN; Gorrod JW
    Anticancer Res; 1988; 8(6):1345-50. PubMed ID: 3218967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds.
    Maxwell DM
    Toxicol Appl Pharmacol; 1992 Jun; 114(2):306-12. PubMed ID: 1609424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice.
    Shapira S; Kadar T; Cohen G; Chapman S; Raveh L
    Arch Toxicol; 1990; 64(8):663-8. PubMed ID: 2090035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice.
    Clement JG
    Biochem Pharmacol; 1984 Dec; 33(23):3807-11. PubMed ID: 6508835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice.
    Clement JG; Benschop HP; DeJong LP; Wolthuis OL
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):141-3. PubMed ID: 3590185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of differential inhibition of hepatic and pancreatic fatty acid ethyl ester synthase by inhibitors of serine-esterases: in vitro and cell culture studies.
    Kaphalia BS; Mericle KA; Ansari GA
    Toxicol Appl Pharmacol; 2004 Oct; 200(1):7-15. PubMed ID: 15451303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
    Maxwell DM; Brecht KM; O'Neill BL
    Toxicol Lett; 1987 Nov; 39(1):35-42. PubMed ID: 3672554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for the inhibition of human monocyte carboxylesterase by organophosphorus compounds.
    Saboori AM; Lang DM; Newcombe DS
    Chem Biol Interact; 1991; 80(3):327-38. PubMed ID: 1954660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition kinetics of acetylcholinesterase and butyrylcholinesterase from various species by 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP).
    Horn G; Rappenglück S; Worek F
    Toxicol Lett; 2024 May; 396():28-33. PubMed ID: 38642675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of esterases reacting with organophosphorus compounds.
    Reiner E; Pavković E; Radić Z; Simeon V
    Chem Biol Interact; 1993 Jun; 87(1-3):77-83. PubMed ID: 8393750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity.
    Wong CC; Cheng KW; Xie G; Zhou D; Zhu CH; Constantinides PP; Rigas B
    J Pharmacol Exp Ther; 2012 Feb; 340(2):422-32. PubMed ID: 22085648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerted role of carboxylesterases in the potentiation of carbofuran toxicity by iso-OMPA pretreatment.
    Gupta RC; Kadel WL
    J Toxicol Environ Health; 1989; 26(4):447-57. PubMed ID: 2709439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of two rat liver microsomal carboxylesterases (hydrolase A and B).
    Morgan EW; Yan B; Greenway D; Petersen DR; Parkinson A
    Arch Biochem Biophys; 1994 Dec; 315(2):495-512. PubMed ID: 7986098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of acetylcholinesterase and general-esterase activity assays using different substrates, in vitro and in vivo exposures and model organisms.
    Cao Y; Herrero-Nogareda L; Cedergreen N
    Ecotoxicol Environ Saf; 2020 Feb; 189():109954. PubMed ID: 31759743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.